ArticleHeart and vessels2026
Renal function-dependent risk of early invasive strategy in patients with non-ST-segment elevation myocardial infarction: insight from KAMIR-NIH and KRAMI-RCC.
Article in Heart and vessels, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Dilemma of Renal Dysfunction and Coronary Artery Revascularization: Insights From Observational Studies.JACC. Asia · 2026Article
- Aortic calcification and contrast-associated acute kidney injury in patients undergoing urgent coronary angiography.Heart and vessels · 2026Article
- Impact of right bundle branch block in anterior ST-segment elevation myocardial infarction in the contemporary primary PCI era.Heart and vessels · 2026Article
Corrections and comments
- Commented on by
Authors and funding
34 authors.
Funding
Abstract
The efficacy of an early invasive strategy (EIS) in NSTEMI patients with renal dysfunction remains unclear. This study assesses the clinical impact of invasive time strategies in NSTEMI patients, stratified by renal function, using data from two major Korean acute myocardial infarction registries. We analyzed a decade-long dataset, combining 5 years each from the Korea Acute Myocardial Infarction-National Institute of Health (KAMIR-NIH) and Registry of Acute Myocardial Infarction for Regional Cardiocerebrovascular Centers (KAMIR-RCC). NSTEMI patients were classified into preserved renal function (PRF, eGFR ≥ 60 mL/min/1.73 m
Indexed as
Identifiers
41176540What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.